Kaposi's Sarcoma Herpesvirus: twenty years after its discovery

P De Paoli, Antonino Carbone

Research output: Contribution to journalArticle

Abstract

Twenty years after the discovery of Kaposi's Sarcoma Herpes Virus (KSHV), many aspects of the pathogenesis have been discovered and innovative approaches are presently applied to the diagnosis and treatment of KSHV associated diseases. The virus is coupled to different types of cancers, as well as to syndromes combined with increased inflammatory response or with immunoreconstitution in immunocompromised hosts. The etiopathological diagnosis of KSHV associated cancers relies on the demonstration of the virus in tumor samples, as well as in the peripheral blood of infected subjects. Novel treatment strategies related to the pathogenetic events of KSHV associated diseases have been recently studied, that are based on drugs able to induce oncolysis by promoting a viral lytic phase or on the blockade of v-IL6, a cytokine with tumor promoting activities. In addition, antiangiogenetic strategies have also been applied to treat KSHV associated cancers. Despite these important discoveries, some aspects of KSHV associated diseases are presently not completely clear and, consequently, response to treatment strategies is still suboptimal.

Original languageEnglish
Pages (from-to)1288-94
Number of pages7
JournalEuropean Review for Medical and Pharmacological Sciences
Volume20
Issue number7
Publication statusPublished - Apr 2016

Fingerprint

Kaposi's Sarcoma
Herpesviridae
Virus Diseases
Viruses
Neoplasms
Oncogenic Viruses
Immunocompromised Host
Interleukin-6
Therapeutics
Cytokines
Pharmaceutical Preparations

Keywords

  • Herpesvirus 8, Human
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Immunocompromised Host
  • Sarcoma, Kaposi
  • Historical Article
  • Journal Article
  • Review

Cite this

Kaposi's Sarcoma Herpesvirus : twenty years after its discovery. / De Paoli, P; Carbone, Antonino.

In: European Review for Medical and Pharmacological Sciences, Vol. 20, No. 7, 04.2016, p. 1288-94.

Research output: Contribution to journalArticle

@article{4cfca9d56da24ab39266ac5904631013,
title = "Kaposi's Sarcoma Herpesvirus: twenty years after its discovery",
abstract = "Twenty years after the discovery of Kaposi's Sarcoma Herpes Virus (KSHV), many aspects of the pathogenesis have been discovered and innovative approaches are presently applied to the diagnosis and treatment of KSHV associated diseases. The virus is coupled to different types of cancers, as well as to syndromes combined with increased inflammatory response or with immunoreconstitution in immunocompromised hosts. The etiopathological diagnosis of KSHV associated cancers relies on the demonstration of the virus in tumor samples, as well as in the peripheral blood of infected subjects. Novel treatment strategies related to the pathogenetic events of KSHV associated diseases have been recently studied, that are based on drugs able to induce oncolysis by promoting a viral lytic phase or on the blockade of v-IL6, a cytokine with tumor promoting activities. In addition, antiangiogenetic strategies have also been applied to treat KSHV associated cancers. Despite these important discoveries, some aspects of KSHV associated diseases are presently not completely clear and, consequently, response to treatment strategies is still suboptimal.",
keywords = "Herpesvirus 8, Human, History, 20th Century, History, 21st Century, Humans, Immunocompromised Host, Sarcoma, Kaposi, Historical Article, Journal Article, Review",
author = "{De Paoli}, P and Antonino Carbone",
year = "2016",
month = "4",
language = "English",
volume = "20",
pages = "1288--94",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "7",

}

TY - JOUR

T1 - Kaposi's Sarcoma Herpesvirus

T2 - twenty years after its discovery

AU - De Paoli, P

AU - Carbone, Antonino

PY - 2016/4

Y1 - 2016/4

N2 - Twenty years after the discovery of Kaposi's Sarcoma Herpes Virus (KSHV), many aspects of the pathogenesis have been discovered and innovative approaches are presently applied to the diagnosis and treatment of KSHV associated diseases. The virus is coupled to different types of cancers, as well as to syndromes combined with increased inflammatory response or with immunoreconstitution in immunocompromised hosts. The etiopathological diagnosis of KSHV associated cancers relies on the demonstration of the virus in tumor samples, as well as in the peripheral blood of infected subjects. Novel treatment strategies related to the pathogenetic events of KSHV associated diseases have been recently studied, that are based on drugs able to induce oncolysis by promoting a viral lytic phase or on the blockade of v-IL6, a cytokine with tumor promoting activities. In addition, antiangiogenetic strategies have also been applied to treat KSHV associated cancers. Despite these important discoveries, some aspects of KSHV associated diseases are presently not completely clear and, consequently, response to treatment strategies is still suboptimal.

AB - Twenty years after the discovery of Kaposi's Sarcoma Herpes Virus (KSHV), many aspects of the pathogenesis have been discovered and innovative approaches are presently applied to the diagnosis and treatment of KSHV associated diseases. The virus is coupled to different types of cancers, as well as to syndromes combined with increased inflammatory response or with immunoreconstitution in immunocompromised hosts. The etiopathological diagnosis of KSHV associated cancers relies on the demonstration of the virus in tumor samples, as well as in the peripheral blood of infected subjects. Novel treatment strategies related to the pathogenetic events of KSHV associated diseases have been recently studied, that are based on drugs able to induce oncolysis by promoting a viral lytic phase or on the blockade of v-IL6, a cytokine with tumor promoting activities. In addition, antiangiogenetic strategies have also been applied to treat KSHV associated cancers. Despite these important discoveries, some aspects of KSHV associated diseases are presently not completely clear and, consequently, response to treatment strategies is still suboptimal.

KW - Herpesvirus 8, Human

KW - History, 20th Century

KW - History, 21st Century

KW - Humans

KW - Immunocompromised Host

KW - Sarcoma, Kaposi

KW - Historical Article

KW - Journal Article

KW - Review

M3 - Article

C2 - 27097948

VL - 20

SP - 1288

EP - 1294

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 7

ER -